Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty
NCT ID: NCT00740480
Last Updated: 2009-08-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2008-04-30
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ENTact™ Septal Stapler Shelf Life Extension
NCT00957502
Safety and Performance of ENTACT Septal Staple System for Septoplasty
NCT04392583
In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia
NCT02880514
A Clinical Evaluation of PROPEL® Contour Sinus Implant
NCT04858802
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)
NCT03358329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* surgical performance of the ENTact Septal Staple System
* one week post op clinical evaluation of gross tissue appearance at implantation site(s)
* ENTact™ Septal Staple functionality based on maintained coaptation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical
Adult population (ages 18-65) with clinically significant nasal septum deviation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is able to provide a signed informed consent form
* Patient will agree to comply with all study related procedures
* Patient is not pregnant at this time. If patient is of child-bearing age and capable of bearing children, a pre-operative pregnancy test confirmation is required to show that patient is not pregnant on the day of surgery
* Patient does not plan on becoming pregnant and is not breast feeding during the course of the study
* Patients who have had previous septoplasty
* Patients with uncontrolled diabetes
* Presence of infection at the site
* Smokers and severe drug and alcohol abusers
* Patients with autoimmune disease deemed clinically significant by Principal Investigator
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ENTrigue Surgical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ENTrigue Surgical, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriele G Niederauer, Ph.D.
Role: STUDY_DIRECTOR
ENTrigue Surgical, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Good Samaritan Hospital
Cincinnati, Ohio, United States
Park Hudson Surgery Center
Bryan, Texas, United States
Physician's Ambulatory Surgery Center IV
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSA 2008-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.